Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-29 @ 7:11 AM
Study NCT ID:
NCT00800267
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2008-11-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
96TIPG005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None